They are experimenting with psychedelic drugs again at UW-Madison.
No, we’re not talking about wide-eyed college students in tie-dyed T-shirts walking along Picnic Point whispering “Oh, Wow” as they do their own “independent research” into spiritualism and religion. self-realization. It was in the 60s.
We’re talking about research, rigorously controlled clinical research, with human trials to see if long-banned drugs like psilocybin (magic mushrooms) can be used to treat depression or addiction. UW researchers are testing MDMA (think the club drug known as ecstasy or molly) to see if it can boost psychotherapy to treat post-traumatic stress disorder.
As editor-in-chief Preston Schmitt reported in the current issue of “On Wisconsin,” the UW alumni magazine, the door was effectively closed on psychedelic research in 1971 when Congress passed the Controlled Substances Act, which stated that psilocybin, LSD and later MDMA had “” no currently accepted medical uses and a high potential for abuse.
“It was highly unlikely that the researchers received the necessary federal approvals to pursue such studies,” Schmitt told us, “And in this climate, given the cultural and political backlash, there was little will to do so. “
This head-in-the-sand approach to psychedelic research has gone on for decades.